首页 | 本学科首页   官方微博 | 高级检索  
检索        

慢性阻塞性肺疾病肺气虚证中医药干预的代谢组学研究初探
引用本文:刘志刚,李泽庚.慢性阻塞性肺疾病肺气虚证中医药干预的代谢组学研究初探[J].国际中医中药杂志,2010,32(6).
作者姓名:刘志刚  李泽庚
作者单位:1. 安徽中医学院,合肥,230038
2. 安徽省中医院呼吸科,合肥,230031
基金项目:国家自然科学基金资助项目,安徽中医学院青年科学研究基金 
摘    要:代谢组学对机体的整体性认识与中医整体观念、辨证论治的思维方法有诸多相同之处,恰当而充分地将代谢组学研究方法应用到中医证候分型诊断、证本质、中医药干预效果、指导临床治疗等方面,可能加快中医药与现代生命科学技术的结合.慢性阻塞性肺疾病(慢阻肺)的中医药研究也将因代谢组学的应用进入新的阶段.本文综述了近年来中医药运用代谢组学技术提高自身理论现代化、科学化、诊疗水平的现状,并对将代谢组学运用到慢阻肺肺气虚证的研究进行了归纳.

关 键 词:代谢组学  慢性阻塞性肺疾病  肺气虚证  中医药

A preliminary metabonomics study of pulmonary-qi deficiency syndrome of COPD intervened with TCM
LIU Zhi-gang,LI Ze-geng.A preliminary metabonomics study of pulmonary-qi deficiency syndrome of COPD intervened with TCM[J].International Journal of Traditional Chinese Medicine,2010,32(6).
Authors:LIU Zhi-gang  LI Ze-geng
Abstract:The rising ofmetabonomics after genomics and proteomics offers chances for the modernization of TCM.Metabonomics has much in common with TCM in the cognition of human body. Appropriate application of the methodology of metabonomics in TCM, such as TCM differential diagnosis and guidance of clinical treatment, would speed up the integration of TCM and modem life science and technology. Meanwhile the research of COPD in TCM will come into a new stage through the use of metabonomics. This article overviewed the current situation of Chinese medicine using metabolomics technology to raise its theory, science and diagnostic level, and the study of pulmonary-qi deficiency syndrome of COPD with metabonomics.
Keywords:Metabonomics  COPD  Pulmonary-qi deficiency syndrom  TCM intervention
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号